Development of NK cell-based cancer immunotherapies through receptor engineering
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Development of NK cell-based cancer immunotherapies through receptor engineering ; volume:21 ; number:4 ; day:5 ; month:3 ; year:2024 ; pages:315-331 ; date:4.2024
Cellular & molecular immunology ; 21, Heft 4 (5.3.2024), 315-331, 4.2024
- Urheber
-
Page, Audrey
Chuvin, Nicolas
Valladeau-Guilemond, Jenny
Depil, Stéphane
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41423-024-01145-x
- URN
-
urn:nbn:de:101:1-2406240941305.312970509144
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Page, Audrey
- Chuvin, Nicolas
- Valladeau-Guilemond, Jenny
- Depil, Stéphane
- SpringerLink (Online service)
Ähnliche Objekte (12)
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia
Challenges of NK cell-based immunotherapy in the new era
Stem cell-based adipose tissue engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
NK cell-based cancer immunotherapy: from basic biology to clinical development
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia
Challenges of NK cell-based immunotherapy in the new era
Stem cell-based adipose tissue engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
NK cell-based cancer immunotherapy: from basic biology to clinical development
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia
Challenges of NK cell-based immunotherapy in the new era
Stem cell-based adipose tissue engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies